Mutze et al. found that low DNMT1 expression predicted better OS and clinical response in 127 patients treated with adjuvant therapy [83], and a comprehensive meta-analysis found that tumor tissues are characterized by high expression levels of DNMT1, with respect to normal, para-cancerous, and dysplastic tissues. Here, DNMT1 is linked to neoplasm.